The global compression therapy industry is undergoing a silent revolution—one that’s redefining how chronic vascular disorders, post-operative recovery, and diabetic complications are managed worldwide. With the market valued at USD 3.9 billion in 2023 and expected to reach USD 5.4 billion by 2030, this isn’t just incremental growth it’s a shift toward accessible, non-invasive, and cost-effective vascular solutions. Driven by the rising prevalence of venous ulcers, deep vein thrombosis (DVT), and lymphedema, demand is expanding across hospitals, rehabilitation centers, and homecare settings.
Our expert transcript dives deep into the evolving dynamics of this market. Today, static compression garments make up over 60% of total sales due to affordability and ease of use, while pneumatic and dynamic devices are accelerating in hospitals and sports recovery clinics. Regionally, North America commands the largest share (~40%) due to reimbursement policies and early diagnosis trends. However, Asia-Pacific is witnessing the fastest growth at over 6% CAGR, backed by expanding ambulatory care, rising public awareness, and the surge of chronic conditions among urban populations. Innovation is a major driver; smart compression sleeves, sensor-based monitoring, and remote adherence tracking are expected to boost patient compliance and long-term outcomes.
Here’s why understanding this market matters now:
Don’t miss out on the full breakdown of trends, forecasts, and expert insights. Download the full transcript now and discover how compression therapy is shaping the future of non-invasive care.